100 related articles for article (PubMed ID: 205356)
1. Increased susceptibility to feline leukemia virus infection in cats exposed to methylnitrosourea.
Schaller JP; Mathes LE; Hoover EA; Koestner A; Olsen RG
Cancer Res; 1978 Apr; 38(4):996-8. PubMed ID: 205356
[TBL] [Abstract][Full Text] [Related]
2. Induction of retinal degeneration in cats by methylnitrosourea and ketamine hydrochloride.
Schaller JP; Wyman M; Weisbrode SE; Olsen RG
Vet Pathol; 1981 Mar; 18(2):239-47. PubMed ID: 6258283
[TBL] [Abstract][Full Text] [Related]
3. Determinants of susceptibility and resistance to feline leukemia virus infection. II. Susceptibility of feline lymphocytes to productive feline leukemia virus infection.
Rojko JL; Hoover EA; Finn BL; Olsen RG
J Natl Cancer Inst; 1981 Oct; 67(4):899-910. PubMed ID: 6268886
[TBL] [Abstract][Full Text] [Related]
4. Enhancement of feline leukemia virus-induced leukemogenesis in cats exposed to methylnitrosourea.
Schaller JP; Mathes LE; Hoover EA; Olsen RG
Int J Cancer; 1979 Nov; 24(5):700-5. PubMed ID: 93586
[TBL] [Abstract][Full Text] [Related]
5. Effects of feline leukemia virus infection on neutrophil chemotaxis in vitro.
Kiehl AR; Fettman MJ; Quackenbush SL; Hoover EA
Am J Vet Res; 1987 Jan; 48(1):76-80. PubMed ID: 3030165
[TBL] [Abstract][Full Text] [Related]
6. Real-time PCR investigation of feline leukemia virus proviral and viral RNA loads in leukocyte subsets.
Cattori V; Pepin AC; Tandon R; Riond B; Meli ML; Willi B; Lutz H; Hofmann-Lehmann R
Vet Immunol Immunopathol; 2008 May; 123(1-2):124-8. PubMed ID: 18304650
[TBL] [Abstract][Full Text] [Related]
7. Study of feline leukemia virus immunity.
Charreyre C; Pedersen NC
J Am Vet Med Assoc; 1991 Nov; 199(10):1316-24. PubMed ID: 1666074
[TBL] [Abstract][Full Text] [Related]
8. Biological effects of staphylococcal protein A immunotherapy in cats with induced feline leukemia virus infection.
Lafrado LJ; Mathes LE; Zack PM; Olsen RG
Am J Vet Res; 1990 Mar; 51(3):482-6. PubMed ID: 1690524
[TBL] [Abstract][Full Text] [Related]
9. Influence of adrenal corticosteroids on the susceptibility of cats to feline leukemia virus infection.
Rojko JL; Hoover EA; Mathes LE; Krakowka S; Olsen RG
Cancer Res; 1979 Sep; 39(9):3789-91. PubMed ID: 225025
[TBL] [Abstract][Full Text] [Related]
10. Mobility of lymphocyte surface membrane concanavalin A receptors of normal and feline leukemia virus-infected viremic felines.
Dunlap JE; Nichols WS; Hebebrand LC; Mathes LE; Olsen RG
Cancer Res; 1979 Mar; 39(3):956-8. PubMed ID: 218726
[TBL] [Abstract][Full Text] [Related]
11. Pathogenesis of experimental feline leukemia virus infection.
Rojko JL; Hoover EA; Mathes LE; Olsen RG; Schaller JP
J Natl Cancer Inst; 1979 Sep; 63(3):759-68. PubMed ID: 224237
[No Abstract] [Full Text] [Related]
12. Feline oncovirus-associated cell membrane antigen and feline leukemia virus group-specific antigen expression in bone marrow and serum.
Rice JB; Olsen RG
J Natl Cancer Inst; 1981 Apr; 66(4):737-43. PubMed ID: 6262553
[TBL] [Abstract][Full Text] [Related]
13. Evaluation of terminal deoxynucleotidyl transferase expression in bone marrow of clinically normal and feline leukemia virus-exposed cats.
Lafrado LJ; Mathes LE; Olsen RG
Am J Vet Res; 1986 Apr; 47(4):820-1. PubMed ID: 3008612
[TBL] [Abstract][Full Text] [Related]
14. Cellular segregation of feline leukemia provirus and viral RNA in leukocyte subsets of long-term experimentally infected cats.
Pepin AC; Tandon R; Cattori V; Niederer E; Riond B; Willi B; Lutz H; Hofmann-Lehmann R
Virus Res; 2007 Jul; 127(1):9-16. PubMed ID: 17434224
[TBL] [Abstract][Full Text] [Related]
15. Demonstration of a syncarcinogenic effect of endogenous MuLV, rescued from MNU-induced leukemias, and suboptimal MNU doses in mice.
Fey F; Ehm I; Drescher B; Rentz E; Seidel G
Neoplasma; 1981; 28(3):265-9. PubMed ID: 6270578
[TBL] [Abstract][Full Text] [Related]
16. Protection of cats against progressive fibrosarcomas and persistent leukemia virus infection by vaccination with feline leukemia cells.
Grant CK; de Noronha F; Tusch C; Michalek MT; McLane MF
J Natl Cancer Inst; 1980 Dec; 65(6):1285-92. PubMed ID: 6253714
[TBL] [Abstract][Full Text] [Related]
17. Retroviral-associated eosinophilic leukemia in the cat.
Lewis MG; Kociba GJ; Rojko JL; Stiff MI; Haberman AB; Velicer LF; Olsen RG
Am J Vet Res; 1985 May; 46(5):1066-70. PubMed ID: 2988377
[TBL] [Abstract][Full Text] [Related]
18. Safety and efficacy studies of live- and killed-feline leukemia virus vaccines.
Pedersen NC; Theilen GH; Werner LL
Am J Vet Res; 1979 Aug; 40(8):1120-6. PubMed ID: 230767
[TBL] [Abstract][Full Text] [Related]
19. 3'-Azido-3'-deoxythymidine in feline leukemia virus-infected cats: a model for therapy and prophylaxis of AIDS.
Tavares L; Roneker C; Johnston K; Lehrman SN; de Noronha F
Cancer Res; 1987 Jun; 47(12):3190-4. PubMed ID: 3034403
[TBL] [Abstract][Full Text] [Related]
20. Vaccination of cats experimentally infected with feline immunodeficiency virus, using a recombinant feline leukemia virus vaccine.
Lehmann R; Franchini M; Aubert A; Wolfensberger C; Cronier J; Lutz H
J Am Vet Med Assoc; 1991 Nov; 199(10):1446-52. PubMed ID: 1666101
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
